Alprenoxime

In this article we will explore the topic of Alprenoxime, which has been the subject of attention and debate in various spheres. Alprenoxime is a concept that has generated interest and controversy due to its impact on today's society. Throughout history, Alprenoxime has played a crucial role in different contexts, and its influence continues to be relevant today. From its origins to its evolution, Alprenoxime has been the object of analysis and reflection by experts and scholars, who have sought to understand its importance and scope in social, cultural and political dynamics. In this sense, it is relevant to comprehensively and critically address the issue of Alprenoxime, in order to offer a broad and enriching perspective that contributes to the knowledge and understanding of this issue.

Alprenoxime
Clinical data
ATC code
  • None
Identifiers
  • 1-(2-allylphenoxy)-3-(isopropylamino)propan-2-one oxime
CAS Number
PubChem CID
ChemSpider
ChEMBL
Chemical and physical data
FormulaC15H22N2O2
Molar mass262.353 g·mol−1
3D model (JSmol)
  • O(c1ccccc1C\C=C)C\C(=N\O)CNC(C)C
  • InChI=1S/C15H22N2O2/c1-4-7-13-8-5-6-9-15(13)19-11-14(17-18)10-16-12(2)3/h4-6,8-9,12,16,18H,1,7,10-11H2,2-3H3/b17-14+ checkY
  • Key:XFQFSSGNEFUEPA-SAPNQHFASA-N checkY
 ☒NcheckY (what is this?)  (verify)

Alprenoxime is a beta blocker.[1] It is a prodrug to alprenolol.[1]

References

  1. ^ a b Prokai L, Wu WM, Somogyi G, Bodor N (May 1995). "Ocular delivery of the beta-adrenergic antagonist alprenolol by sequential bioactivation of its methoxime analogue". Journal of Medicinal Chemistry. 38 (11): 2018–20. doi:10.1021/jm00011a021. PMID 7783133.



Stub icon

This antihypertensive-related article is a stub. You can help Wikipedia by expanding it.